90 related articles for article (PubMed ID: 15703842)
1. From molecular characteristics to cellular events in apoptosis-resistant HL-60 cells.
Palissot V; Morjani H; Belloc F; Cotteret S; Dufer J; Berchem G
Int J Oncol; 2005 Mar; 26(3):825-34. PubMed ID: 15703842
[TBL] [Abstract][Full Text] [Related]
2. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
Wu CH; Rastegar M; Gordon J; Safa AR
Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
[TBL] [Abstract][Full Text] [Related]
3. Factors contributing to the resistance to apoptosis induced by topoisomerase I inhibitors in vincristine resistant cells.
Palissot V; Trussardi A; Gorisse MC; Dufer J
Adv Exp Med Biol; 1999; 457():355-63. PubMed ID: 10500811
[TBL] [Abstract][Full Text] [Related]
4. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression.
Liang R; Chen XQ; Bai QX; Wang Z; Zhang T; Yang L; Dong BX; Gao GX; Gu HT; Zhu HF
Acta Haematol; 2014; 132(2):177-86. PubMed ID: 24603438
[TBL] [Abstract][Full Text] [Related]
5. Resistance to apoptosis induced by topoisomerase I inhibitors in multidrug-resistant HL60 leukemic cells.
Palissot V; Belhoussine R; Carpentier Y; Sebille S; Morjani H; Manfait M; Dufer J
Biochem Biophys Res Commun; 1998 Apr; 245(3):918-22. PubMed ID: 9588215
[TBL] [Abstract][Full Text] [Related]
6. [Multidrug resistance mechanisms in cell line HL-60/VCR].
Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
[TBL] [Abstract][Full Text] [Related]
7. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells.
Belhoussine R; Morjani H; Gillet R; Palissot V; Manfait M
Adv Exp Med Biol; 1999; 457():365-81. PubMed ID: 10500812
[TBL] [Abstract][Full Text] [Related]
8. PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.
Duraj J; Takacsova X; Sedlak J; Sulikova M; Hunakova L; Bies J; Chorvath B
Anticancer Res; 2000; 20(6B):4627-32. PubMed ID: 11205313
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
10. High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion.
Keeshan K; Cotter TG; McKenna SL
Leukemia; 2002 Sep; 16(9):1725-34. PubMed ID: 12200687
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
12. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
13. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.
Amarante-Mendes GP; McGahon AJ; Nishioka WK; Afar DE; Witte ON; Green DR
Oncogene; 1998 Mar; 16(11):1383-90. PubMed ID: 9525737
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
Yoshida A; Takemura H; Inoue H; Miyashita T; Ueda T
Cancer Res; 2006 Jun; 66(11):5772-80. PubMed ID: 16740716
[TBL] [Abstract][Full Text] [Related]
16. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transduction.
Zhao Y; Xiao B; Chen B; Qiao T; Fan D
Chin Med J (Engl); 2000 Nov; 113(11):977-80. PubMed ID: 11776130
[TBL] [Abstract][Full Text] [Related]
18. Blocking of PI3K/Akt pathway enhances apoptosis induced by SN-38, an active form of CPT-11, in human hepatoma cells.
Koizumi N; Hatano E; Nitta T; Tada M; Harada N; Taura K; Ikai I; Shimahara Y
Int J Oncol; 2005 May; 26(5):1301-6. PubMed ID: 15809721
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent apoptosis in melanoma cells after treatment with camptothecin.
Li G; Bush JA; Ho VC
J Invest Dermatol; 2000 Mar; 114(3):514-9. PubMed ID: 10692111
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells.
Lansiaux A; Facompré M; Wattez N; Hildebrand MP; Bal C; Demarquay D; Lavergne O; Bigg DC; Bailly C
Mol Pharmacol; 2001 Sep; 60(3):450-61. PubMed ID: 11502875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]